267 related articles for article (PubMed ID: 15351965)
41. Low levels of the vascular endothelial growth factor in CSF from early ALS patients.
Devos D; Moreau C; Lassalle P; Perez T; De Seze J; Brunaud-Danel V; Destée A; Tonnel AB; Just N
Neurology; 2004 Jun; 62(11):2127-9. PubMed ID: 15184633
[TBL] [Abstract][Full Text] [Related]
42. Enhancing Angiogenesis in Mice by VEGF-Targeting Small Activating RNAs.
Turunen TA; Ylä-Herttuala S; Turunen MP
Adv Exp Med Biol; 2017; 983():195-205. PubMed ID: 28639201
[TBL] [Abstract][Full Text] [Related]
43. Novel function of VEGF-B as an antioxidant and therapeutic implications.
Chen R; Lee C; Lin X; Zhao C; Li X
Pharmacol Res; 2019 May; 143():33-39. PubMed ID: 30851357
[TBL] [Abstract][Full Text] [Related]
44. Is VEGF a Key Target of Cotinine and Other Potential Therapies Against Alzheimer Disease?
Echeverria V; Barreto GE; Avila-Rodriguezc M; Tarasov VV; Aliev G
Curr Alzheimer Res; 2017; 14(11):1155-1163. PubMed ID: 28356047
[TBL] [Abstract][Full Text] [Related]
45. VEGF and ALS: the luckiest growth factor?
Greenberg DA; Jin K
Trends Mol Med; 2004 Jan; 10(1):1-3. PubMed ID: 14720577
[No Abstract] [Full Text] [Related]
46. Polyglutamine diminishes VEGF; passage to motor neuron death?
Katsuno M; Sobue G
Neuron; 2004 Mar; 41(5):677-9. PubMed ID: 15003165
[TBL] [Abstract][Full Text] [Related]
47. Modulation of vascular endothelial growth factor (VEGF) expression in motor neurons and its electrophysiological effects.
McCloskey DP; Hintz TM; Scharfman HE
Brain Res Bull; 2008 May; 76(1-2):36-44. PubMed ID: 18395608
[TBL] [Abstract][Full Text] [Related]
48. Insights into the Mechanisms Involved in Protective Effects of VEGF-B in Dopaminergic Neurons.
Caballero B; Sherman SJ; Falk T
Parkinsons Dis; 2017; 2017():4263795. PubMed ID: 28473940
[TBL] [Abstract][Full Text] [Related]
49. Vascular endothelial growth factor: a neurovascular target in neurological diseases.
Lange C; Storkebaum E; de Almodóvar CR; Dewerchin M; Carmeliet P
Nat Rev Neurol; 2016 Aug; 12(8):439-54. PubMed ID: 27364743
[TBL] [Abstract][Full Text] [Related]
50. Optogenetics and its application in neural degeneration and regeneration.
Ordaz JD; Wu W; Xu XM
Neural Regen Res; 2017 Aug; 12(8):1197-1209. PubMed ID: 28966628
[TBL] [Abstract][Full Text] [Related]
51. VEGF Paradoxically Reduces Cerebral Blood Flow in Alzheimer's Disease Mice.
Ali M; Bracko O
Neurosci Insights; 2022; 17():26331055221109254. PubMed ID: 35873789
[TBL] [Abstract][Full Text] [Related]
52. VEGF as a target for neuroprotection.
Vezzani A
Epilepsy Curr; 2008; 8(5):135-7. PubMed ID: 18852838
[No Abstract] [Full Text] [Related]
53. VEGF in Signaling and Disease: Beyond Discovery and Development.
Apte RS; Chen DS; Ferrara N
Cell; 2019 Mar; 176(6):1248-1264. PubMed ID: 30849371
[TBL] [Abstract][Full Text] [Related]
54. Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension.
Bertero T; Oldham WM; Cottrill KA; Pisano S; Vanderpool RR; Yu Q; Zhao J; Tai Y; Tang Y; Zhang YY; Rehman S; Sugahara M; Qi Z; Gorcsan J; Vargas SO; Saggar R; Saggar R; Wallace WD; Ross DJ; Haley KJ; Waxman AB; Parikh VN; De Marco T; Hsue PY; Morris A; Simon MA; Norris KA; Gaggioli C; Loscalzo J; Fessel J; Chan SY
J Clin Invest; 2016 Sep; 126(9):3313-35. PubMed ID: 27548520
[TBL] [Abstract][Full Text] [Related]
55. Molecular mechanisms and clinical applications of angiogenesis.
Carmeliet P; Jain RK
Nature; 2011 May; 473(7347):298-307. PubMed ID: 21593862
[TBL] [Abstract][Full Text] [Related]
56. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.
Ricci-Vitiani L; Pallini R; Biffoni M; Todaro M; Invernici G; Cenci T; Maira G; Parati EA; Stassi G; Larocca LM; De Maria R
Nature; 2010 Dec; 468(7325):824-8. PubMed ID: 21102434
[TBL] [Abstract][Full Text] [Related]
57. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction.
Fantin A; Vieira JM; Gestri G; Denti L; Schwarz Q; Prykhozhij S; Peri F; Wilson SW; Ruhrberg C
Blood; 2010 Aug; 116(5):829-40. PubMed ID: 20404134
[TBL] [Abstract][Full Text] [Related]
58. Why do cancers have high aerobic glycolysis?
Gatenby RA; Gillies RJ
Nat Rev Cancer; 2004 Nov; 4(11):891-9. PubMed ID: 15516961
[TBL] [Abstract][Full Text] [Related]
59. Relation of Cognitive Impairment with Number of Acute Exacerbations and Serum Level of VEGF among COPD Patients.
Samareh Fekri M; Nagibzadeh Tahami A; Arabnejad F
Tanaffos; 2023 Mar; 22(3):311-316. PubMed ID: 38638387
[TBL] [Abstract][Full Text] [Related]
60. Neuroprotective Effects of Human Adipose-Derived Mesenchymal Stem Cells in Oxygen-Induced Retinopathy.
Xin J; Zhou L; Zhang L; Guo K; Yang D
Cell Transplant; 2023; 32():9636897231213309. PubMed ID: 38018498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
